🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Treatment Acquiring Traction Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a robust trade exists on messaging services, where groups with thousands of members share comparison photos, injection guides and claims of next-day British shipping. Vendors promote the substance there before directing customers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Express Worries

Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in users injecting substances of unknown origin.

Some experts said the demand for the experimental drug could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate pharmaceutical, advertising, and consumer laws, potentially leading to penalties, legal action or imprisonment.

Platform Response and Content Elimination

Based on the social media company, the service has removed problematic material and prohibited related hashtags and search suggestions. The company stated it was committed to maintaining the platform secure and allocating resources in enhancing enforcement strategies.

Online Trading Activities

Investigations also found communities with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, populated with photos of weight loss, positive reviews and detailed guides for preparing or injecting at home.

Within minutes of joining one community, a seller posted contact information, where the majority of transactions take place. The seller sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.

Item Information and Costs

Inside these communities, posts show dark colored packages with postal service labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When questioned how long a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A representative for Telegram stated it regularly monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is valid, these digital products may not contain what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in interest to recent cost increases for approved slimming medications such as Mounjaro. “With costs increasing, patients are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.

Her team has previously encountered patients injured by personal administration from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose patients to potentially serious health risks”.